You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《半日速報》恆指半日收報20,209點 跌99點; 恆生科技指數半日收報4,120點 跌46點 藥明生物升逾5% 中石油、麗珠醫藥、建發國際集團、同仁堂國藥、綠城管理控股創新高
恆指半日收20,209點,跌99點或0.5%。恆生科技指數報4,120點,跌46點或1.1%。國指跌42點或0.6%,報6,824點。 活躍重磅股表現: 阿里巴巴(09988.HK) 收93.75元,下跌2.4%; 平安(02318.HK) 收50.85元,下跌1.8%; 美團(03690.HK) 收128.8元,下跌1.7%; 友邦(01299.HK) 收84.8元,下跌1%; 騰訊(00700.HK) 收359.4元,上升0.6%; 建行(00939.HK) 收5.23元,下跌0.4%; 異動恆指及國指成份股: 藥明生物(02269.HK) 收52.75元,上升5.6%; 碧桂園(02007.HK) 收2.32元,下跌3.7%; 商湯-W(00020.HK) 收3.05元,下跌3.5%; 銀娛(00027.HK) 收53.4元,下跌3.3%; 京東集團(09618.HK) 收148.3元,下跌3.1%; 中石油(00857.HK) 收5.03元,上升1%,創新高; 異動綜合中小型股: 復星旅遊文化(01992.HK) 收8.82元,下跌12.8%; 麗珠醫藥(01513.HK) 收29.8元,上升3.1%,創新高; 建發國際集團(01908.HK) 收27.3元,上升2.4%,創新高; 同仁堂國藥(03613.HK) 收14.52元,上升1.8%,創新高; 綠城管理控股(09979.HK) 收7.88元,上升1.7%,創新高; ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account